O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+11.18%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.5B
AUM Growth
+$9.5B
(+8.1%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
1.57%
Top 10 Holdings %
Top 10 Hldgs %
34.99%
Holding
144
New
11
Increased
35
Reduced
32
Closed
10
Top Buys
| 1 |
Cigna
CI
|
$205M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$197M |
| 3 |
Gilead Sciences
GILD
|
$90.1M |
| 4 |
Viatris
VTRS
|
$65.2M |
| 5 |
Biogen
BIIB
|
$52.4M |
Top Sells
| 1 |
Centene
CNC
|
$118M |
| 2 |
HCA Healthcare
HCA
|
$100M |
| 3 |
Pfizer
PFE
|
$99M |
| 4 |
Tenet Healthcare
THC
|
$94.8M |
| 5 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$74.8M |
Sector Composition
| 1 | Healthcare | 92.98% |
| 2 | Financials | 1.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
51
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $57.9M | 0.61% | 1,287,588 +383,888 | +42% | +$17.3M |
|
52
Select Medical
SEM
$1.61B
| $56.6M | 0.59% | 3,687,400 +1,601,100 | +77% | +$24.6M |
|
|
GWPH
53
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $56.2M | 0.59% | 561,071 +85,171 | +18% | +$8.54M |
|
|
54
HCA Healthcare
HCA
$94.5B
| $52.1M | 0.55% | 597,400 -1,147,600 | -66% | -$100M |
|
55
Alnylam Pharmaceuticals
ALNY
$58.5B
| $51M | 0.53% | 639,200 +557,000 | +678% | +$44.4M |
|
56
Bristol-Myers Squibb
BMY
$96B
| $48.7M | 0.51% | 874,700 -1,036,300 | -54% | -$57.7M |
|
57
Intuitive Surgical
ISRG
$170B
| $45.1M | 0.47% | 48,200 -2,200 | -4% | -$2.06M |
|
58
Stryker
SYK
$150B
| $43.9M | 0.46% | 316,300 | – | – |
|
|
IMMU
59
DELISTED
Immunomedics Inc
IMMU
| $43.5M | 0.46% | 4,928,958 +3,696,858 | +300% | +$32.6M |
|
60
Intellia Therapeutics
NTLA
$1.22B
| $42.6M | 0.45% | 2,662,180 | – | – |
|
|
BLUE
61
DELISTED
bluebird bio
BLUE
| $42M | 0.44% | 399,800 +116,000 | +41% | +$12.2M |
|
|
DERM
62
DELISTED
Dermira, Inc.
DERM
| $41.3M | 0.43% | 1,418,873 +395,200 | +39% | +$11.5M |
|
|
NBRV
63
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $41.1M | 0.43% | 3,919,600 +2,241,660 | +134% | +$23.5M |
|
|
PVLA
64
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $36.7M | 0.39% | 7,259,620 | – | – |
|
65
Cartesian Therapeutics
RNAC
$261M
| $36.6M | 0.38% | 1,842,797 | – | – |
|
|
EVHC
66
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $36.2M | 0.38% | +578,100 | New | +$36.2M |
|
|
MNTA
67
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $35.6M | 0.37% | 2,109,068 | – | – |
|
68
eHealth
EHTH
$118M
| $34.5M | 0.36% | 1,834,700 +14,700 | +0.8% | +$276K |
|
|
NVRO
69
DELISTED
NEVRO CORP.
NVRO
| $33.6M | 0.35% | 451,300 +373,500 | +480% | +$27.8M |
|
|
RDUS
70
DELISTED
Radius Health, Inc.
RDUS
| $31.8M | 0.33% | 704,100 | – | – |
|
|
OTIC
71
DELISTED
Otonomy, Inc.
OTIC
| $29.4M | 0.31% | 1,559,074 -291,020 | -16% | -$5.49M |
|
|
IMGN
72
DELISTED
Immunogen Inc
IMGN
| $28M | 0.29% | 3,938,272 -2,157,375 | -35% | -$15.3M |
|
|
JUNO
73
DELISTED
Juno Therapeutics, Inc.
JUNO
| $27.4M | 0.29% | +915,208 | New | +$27.4M |
|
|
STDY
74
DELISTED
SteadyMed Ltd
STDY
| $26.8M | 0.28% | 4,246,196 +1,174,000 | +38% | +$7.4M |
|
75
Iovance Biotherapeutics
IOVA
$807M
| $25.2M | 0.26% | 3,382,900 | – | – |
|